Sudhir Mehta steps down as Director of Torrent Pharma Ruchika Sharma3 April 2024 4:09 PM ISTAhmedabad: Torrent Pharma has announced that Sudhir Mehta has stepped down as Director of the Company effective 31-Mar-24. He will continue to be...
Bharat Biotech, SII arm Bilthoven Biologicals collaborate to produce, supply Oral polio vaccine Ruchika Sharma3 April 2024 1:30 PM ISTThrough this collaboration, BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India...
Kenvue India, API join hands to release Recommendations on Oral Fluid Electrolytes, Energy Management for Hospitalized Patients with Non-Diarrheal Illnesses Kajal Rajput3 April 2024 1:00 PM ISTNew Delhi: Kenvue, the world's largest pure-play consumer health company by revenue, released a whitepaper addressing challenges in Oral Fluid,...
AstraZeneca, Daiichi Sankyo Datopotamab deruxtecan application accepted in US for pretreated metastatic HR-positive, HER2-negative breast cancer Ruchika Sharma3 April 2024 12:30 PM ISTAstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the...
Abbott gets USFDA approval for TriClip TEER System for Tricuspid Regurgitation Ruchika Sharma3 April 2024 11:46 AM ISTAbbott Park, III.: Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip...
Abbott gets USFDA clearance for whole blood rapid test to help with assessment of concussion at patient bedside Ruchika Sharma2 April 2024 5:30 PM ISTWith this clearance, the i-STAT TBI test can be used to help evaluate patients up to 24 hours after injury, an advancement since those injured often...
Alembic Pharma gets tentative USFDA nod for breast cancer drug Ribociclib in March Quarter Ruchika Sharma2 April 2024 3:17 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that the Company has received tentative approval for Ribociclib Tablets, 200 mg,...
Zydus Lifesciences gets WHO INN approval for 'Usnoflast' as recommended name for ZYIL1 Ruchika Sharma2 April 2024 1:30 PM ISTUsnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus.
Lupin bags tentative USFDA nod for Migalastat Capsules Ruchika Sharma2 April 2024 12:30 PM ISTMigalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene...
Alembic Pharma ropes in Manish Kejriwal as Independent Director Ruchika Sharma2 April 2024 11:33 AM ISTMumbai: Alembic Pharmaceuticals Limited has appointed Manish Kejriwal as an Independent Director of the company for the period of five...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
USFDA nod to Voydeya as add on therapy to ravulizumab or eculizumab for extravascular haemolysis in adults with rare disease PNH: AstraZeneca Ruchika Sharma1 April 2024 3:18 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the...
